Validation of Bedaquiline Phenotypic Drug Susceptibility Testing Methods and Breakpoints: a Multilaboratory, Multicountry Study.

Antitubercular Agents / pharmacology Diarylquinolines Humans Microbial Sensitivity Tests Mycobacterium tuberculosis Pharmaceutical Preparations Reproducibility of Results
Mycobacterium tuberculosis bedaquiline drug resistance drug susceptibility testing tuberculosis variants

Journal

Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564

Informations de publication

Date de publication:
25 03 2020
Historique:
received: 08 10 2019
accepted: 13 01 2020
pubmed: 24 1 2020
medline: 24 6 2021
entrez: 24 1 2020
Statut: epublish

Résumé

Drug-resistant tuberculosis persists as a major public health concern. Alongside efficacious treatments, validated and standardized drug susceptibility testing (DST) is required to improve patient care. This multicountry, multilaboratory external quality assessment (EQA) study aimed to validate the sensitivity, specificity, and reproducibility of provisional bedaquiline MIC breakpoints and World Health Organization interim critical concentrations (CCs) for categorizing clinical

Identifiants

DOI: 10.1128/JCM.01677-19 PMID: 31969421 PMC: PMC7098739
pubmed: 31969421
pii: JCM.01677-19
doi: 10.1128/JCM.01677-19
pmc: PMC7098739
pii:
doi:

Substances chimiques

Antitubercular Agents 0
Diarylquinolines 0
Pharmaceutical Preparations 0
bedaquiline 78846I289Y

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 Kaniga et al.

Références

EBioMedicine. 2018 Feb;28:136-142
pubmed: 29337135
PLoS One. 2014 Jul 10;9(7):e102135
pubmed: 25010492
Science. 2005 Jan 14;307(5707):223-7
pubmed: 15591164
Antimicrob Agents Chemother. 2014 May;58(5):2979-81
pubmed: 24590481
J Antimicrob Chemother. 2017 Jul 1;72(7):1901-1906
pubmed: 28387862
Eur Respir J. 2018 Dec 20;52(6):
pubmed: 30361246
N Engl J Med. 2014 Aug 21;371(8):723-32
pubmed: 25140958
Antimicrob Agents Chemother. 2018 Aug 27;62(9):
pubmed: 29941636
Mol Biol (Mosk). 2018 May-Jun;52(3):435-450
pubmed: 29989575
J Antimicrob Chemother. 2015 Aug;70(8):2300-5
pubmed: 25977401
N Engl J Med. 2015 Nov 12;373(20):1986-8
pubmed: 26559594
J Clin Microbiol. 2006 Mar;44(3):688-92
pubmed: 16517840
Antimicrob Agents Chemother. 2015 Jul;59(7):4352-5
pubmed: 25941226
J Antimicrob Chemother. 2015 Sep;70(9):2507-10
pubmed: 26045528
J Antimicrob Chemother. 2017 Mar 1;72(3):684-690
pubmed: 28031270
Antimicrob Agents Chemother. 2010 Mar;54(3):1022-8
pubmed: 20038615
Bull World Health Organ. 2012 Sep 1;90(9):693-8
pubmed: 22984314
Eur Respir J. 2017 May 21;49(5):
pubmed: 28529207
J Clin Microbiol. 2016 Dec;54(12):2956-2962
pubmed: 27654337
J Clin Microbiol. 2016 Dec;54(12):2963-2968
pubmed: 27654338
Antimicrob Agents Chemother. 2016 Jul 22;60(8):4590-9
pubmed: 27185800
Am J Respir Crit Care Med. 2016 Feb 1;193(3):337-40
pubmed: 26829425
Lancet Respir Med. 2018 Sep;6(9):699-706
pubmed: 30001994
Eur Respir J. 2015 Feb;45(2):317-21
pubmed: 25653264
Front Microbiol. 2019 Apr 16;10:794
pubmed: 31057511

Auteurs

Koné Kaniga (K)

Johnson & Johnson Global Public Health, Titusville, New Jersey, USA kkaniga@its.jnj.com.

Akio Aono (A)

Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan Anti-tuberculosis Association, Kiyose, Japan.

Emanuele Borroni (E)

Emerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
ORCID: 0000-0001-6780-5119

Daniela Maria Cirillo (DM)

Emerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
ORCID: 0000-0001-6415-1535

Christel Desmaretz (C)

Department of Biomedical Sciences, Mycobacteriology Unit, Institute of Tropical Medicine, Antwerp, Belgium.

Rumina Hasan (R)

Department of Pathology and Laboratory Medicine, The Aga Khan University, Karachi, Pakistan.
Faculty of Infectious and Tropical Disease, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Lavania Joseph (L)

Center for Tuberculosis, National and WHO Supranational TB Reference Laboratory, National Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.

Satoshi Mitarai (S)

Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan Anti-tuberculosis Association, Kiyose, Japan.

Sadia Shakoor (S)

Department of Pathology and Laboratory Medicine, The Aga Khan University, Karachi, Pakistan.

Gabriela Torrea (G)

Department of Biomedical Sciences, Mycobacteriology Unit, Institute of Tropical Medicine, Antwerp, Belgium.

Nazir Ahmed Ismail (NA)

Center for Tuberculosis, National and WHO Supranational TB Reference Laboratory, National Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
Department of Medical Microbiology, University of Pretoria, Pretoria, South Africa.
Department of Internal Medicine, University of Witwatersrand, Johannesburg, South Africa.

Shaheed V Omar (SV)

Center for Tuberculosis, National and WHO Supranational TB Reference Laboratory, National Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Antituberculeux › Validation of Bedaquiline Phenotypic Drug...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › Quinoléines › Diarylquinoléines › Validation of Bedaquiline Phenotypic Drug...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Validation of Bedaquiline Phenotypic Drug...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Validation of Bedaquiline Phenotypic Drug...
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Bâtonnets à Gram positif › Bâtonnets asporogènes à Gram positif › Bâtonnets asporogènes réguliers à Gram positif › Mycobacteriaceae › Mycobacterium › Mycobacterium tuberculosis › Validation of Bedaquiline Phenotypic Drug...
questionsmedicales.fr › Préparations pharmaceutiques › Validation of Bedaquiline Phenotypic Drug...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Méthodologie en recherche épidémiologique › Reproductibilité des résultats › Validation of Bedaquiline Phenotypic Drug...